CD34 and systemic lupus erythematosus: The use of CB-derived cells would be acting as a “naive” CD34+ hematopoietic progenitor cell population that has not been affected by the BM microenvironment, therefore providing a reference point for BM-derived CD34+ HPSC intrinsic differences between healthy and SLE patients.